Home > Financial Ratios > AARTI DRUGS

AARTI DRUGS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for AARTI DRUGS
Please provide your vote to see the results

AARTI DRUGS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 4.24-9.38-22.7066.6325.16

What is the latest Core EBITDA Growth ratio of AARTI DRUGS ?

The latest Core EBITDA Growth ratio of AARTI DRUGS is 4.24 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar20244.24
Mar2023-9.38
Mar2022-22.70
Mar202166.63
Mar202025.16

How is Core EBITDA Growth of AARTI DRUGS Trending?

Years Core EBITDA Growth % Change
Mar2024 4.24
Positive
Mar2023 -9.38
Negative
Mar2022 -22.7
Negative
Mar2021 66.63
164.83
Mar2020 25.16 -

Other Financial Ratios of AARTI DRUGS


Compare Core EBITDA Growth ratio of peers of AARTI DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI DRUGS ₹3,499.1 Cr -7.8% -9% -25.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,044.0 Cr -0.2% -1% 9.8% Stock Analytics
DIVIS LABORATORIES ₹159,537.0 Cr -2.1% 1.5% 61.3% Stock Analytics
CIPLA ₹118,889.0 Cr -0% 2% -0.5% Stock Analytics
DR REDDYS LABORATORIES ₹102,075.0 Cr -1.4% -6.1% -4% Stock Analytics
ZYDUS LIFESCIENCES ₹94,832.5 Cr -5.2% -4.7% 8.9% Stock Analytics


AARTI DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI DRUGS

-7.8%

-9%

-25.5%

SENSEX

-2.5%

-0.8%

7.1%


You may also like the below Video Courses